
Summary
The drug-affinity-complex (DAC) modified variant of CJC-1295 — a GHRH analog with a lysine linker and maleimido-propionic acid for extended serum half-life in research models.
Research context
Teichman et al., J Clin Endocrinol Metab (2006) — characterization of the DAC-conjugated GHRH analog.
Research use only
This product is for laboratory research use only. Not for human or veterinary use. Not a drug, supplement, or medical device. By purchasing, customer certifies research use per our Terms of Sale.
